Post on 05-Nov-2015
description
Oleh :IDH Mutations in Primary Myelofibrosis Predict Leukemic Transformation and Shortened Survival: Clinical Evidence for Leukemogenic Collaboration with JAK2V617FPROGRAM STUDI BIOTEKNOLOGI, SEKOLAH PASCASARJANAUNIVERSITAS GADJAH MADAYOGYAKARTA2013
Background Primary MyelofibrosisSumsum TulangJAK2(70%), IDH, TET2. LNK, ASXL1, CBL
JAK2IDH
Material and MethodsSebanyak 301 pasien diikutsertakan dalam penelitianInformed written consent
Detection of JAK2, MPL, IDH1 and IDH2 Mutation
Dihitung berdasarkan pertama kali data diambil hingga kematian atau kontak terakhirDihitung berdasarkan pertama kali data diambil hingga leukemic transformation, kematian atau kontak terakhir
10 cmResult and Discussion
Figure 1 Overall survival data for 301 patients with primary myelofibrosis stratified by the presence or absence of IDH, MPL and JAK2 mutations.
Figure 2 Overall survival data for 301 patients with primary myelofibrosis stratified by the presence or absence of MPL, JAK2 or IDH mutations with or without concomitant JAK2V617F expression.
Figure 3 Leukemia-free survival data for 301 patients with primary myelofibrosis stratified by the presence or absence of IDH, MPL and JAK2 mutations.
Figure 4 Leukemia-free survival data for 301 patients with primary myelofibrosis stratified by the presence or absence of MPL, JAK2 or IDH mutations with or without concomitant JAK2V617F expression.
****